top of page


Previous postdocs and students from the Arginine Methylation Laboratory


Moving on to new pastures, but still very much missed 



Dr Agnieszka Zielinska


After completing her post-doc in the Davies Lab working on the identification of novel PRMT1 substrates in breast cancer and developing state-of-the-art in vivo mouse techniques, Agnieszka is now working as a technical manager at the University of Birmingham.

DS profile_edited.jpg

Dr Pilar Sanchez-Bailon


Pilar identified the deubiquitylating enzyme, USP11, as a new PRMT1 substrate and has characterised a role for methyl-USP11 in the repair of double strand breaks by homologous recombination. She is now completing a second post-doc in the Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany.

Dr Debashish Sahay

india flag.png

Debashish worked on drug treating breast cancer xenograft models with pre-clinical PRMT5 inhibitors to understand breast cancer stem cell function. He has now moved to the USA to work with Johnson and Johnson Pharmaceuticals. 


matthew website_edited.jpg

Dr Thomas Clarke


After completing his PhD in the Davies Lab understanding how PRMT5 regulates homologous-recombination-mediated DSB repair, Tom was awarded an EMBO Long-Term Fellowship to join the lab of Dr Johnathan Whetstine (MGH, Harvard) to work on lysine demethylases and aberrant copy number gains in cancer. He is now working in the lab of Dr Raul Mostoslavsky, (MGH, Harvard) investigating acetylation and the DNA damage response. 

Dr James Jarrold


After completing a PhD using quantitative proteomics to understand how PRMT1 functions in breast cancer, James is now working as a post-doc at Warwick University. 

Dr Krystian Ubych


School of Chemisty, with Dr. Rob Neely

Krystian completed his PhD in the lab of Dr. Robert Neely and Dr. Francisco Fernandez-Trillo (University of Birmingham) and was involved in studies of DNA methylation using a combination of organic chemistry, enzyme-based methods and fluorescence imaging. During this time, I got an opportunity to explore the epigenetics of cancer thanks to collaboration with Dr. Clare Davies’ group. After a short postdoc in the Neely lab, Krystian is now a Senior Scientist at Tagomics Ltd, Birmingham.

Dr Matthew Gillespie


Matthew's PhD studies involved understanding the role of PRMT5 in promoting chemoresistance of breast cancer stem cells. He is now working as a post-doc at Southampton University. 

Dr Elizabeth Dufficy 


Lizzie completed her iCASE AstraZeneca PhD studentship studying the dynamic modulation of PRMT5 activity after DNA damage. She is now working as a Postdoctoral researcher in Prof. Jason Parson's lab at the University of Birmingham.


Charlie Brockwell - Intercalating Medic into the BMedSc programme
Fiona Black - 
Undergraduate professional training year (Cardiff University) (now undertaking a PhD)
Hannah Rouse - MSci (now undertaking a PhD)
Zac Sandy - MRes Cancer Sciences (now undertaking a PhD)
Lisa Pfeuffer (ERASMUS student from Germany) (now undertaking a PhD)
James Van Hear - MSci (now undertaking a PhD)
Wendy Allen - MSci (now undertaking a PhD)
Summik Limbu - MSci (now undertaking a PhD)

Chowmia Muraleetharan - MSci

Paige Shaw - MRes Cancer Sciences
Lauren Pitt - MRes Cancer Sciences
Sophie Ord - MRes Cancer Sciences

bottom of page